MRVI INVESTOR NOTICE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

SAN DIEGO, March 19, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, all dates inclusive (the "Class Period"), have until May 5, 2025 to seek appointment as lead plaintiff of the Maravai class action lawsuit.  Captioned Nelson v. Maravai LifeSciences Holdings, Inc., No. 25-cv-00499 (S.D. Cal.), the Maravai class action lawsuit charges Maravai as well as ...